Prof. Dr.
Mutlu ARAT

Randevu Al
İstanbul Florence Nightingale Hastanesi
Özel İlgi Alanları
  • Lösemi, Lenfoma, Multipl Miyelom
  • GVHH Geç Yan Etkiler
  • Kemik İliği
  • Lenf
Sağlık Rehberi İçerikleri

    Video

      • 2010
        Şişli Florence Nightingale Hastanesi
        Kemik İliği Nakli Merkezi / Kurucu

        2009
        Ankara Üniversitesi Tıp Fakültesi
        Komite Başkanlığı

        2001
        Ankara Üniversitesi
        Hematoloji Yandal Eğitimi

        1996
        Hacettepe Üniversitesi 
        Tıp Eğitimi

        1991
        Ankara Üniversitesi 
        İç Hastalıkları Uzmanlık Eğitimi

        • European Blood and Marrow Transplantation Group (EBMT)
          • LEWP secretary (2006 - 2012)
        • Joint Accreditation Committee ISHAGE Europe (JACIE)
          • Inspector (Clinic/Collection Facility) (31.08.2004 -  )
        • European Hematology Association (EHA) (# 3873)
          • EHA Education Committee (2009 - 2013)
        • American Society of Hematology (ASH, #1001725)
        • American Society of Transplantation and Cellular Therapy (ASTCT, #3196)
        • Türk Hematoloji Derneği
          • Genel Sekreter (2004 - 2010)
          • KİT Bilimsel Komitesi Başkanı (2013 – 2018)
        • Türk Aferez Derneği, Kurucu Üye
        • Turkish Journal of Hematology Associate Editor (2004 - 2011)
        • Ege Journal of Medicine: Review Board (Internal Medicine)
        • Hematology/Oncology and Stem Cell Therapy: International Editorial Board

    • Uluslararası Hakemli Dergilerde Yayımlanan Makaleler

        • Bekoz H, Ozbalak M, Karadurmus N, Paydas S, Turker A, Toptas T, Tuglular TF, Altuntas F, Cakar MK, Sonmez M, Gulbas Z, Demir N, Kaynar L, Yildirim R, Karadogan I, Arat M, Kapucu I, Aslan NA, Ozkocaman V, Turgut M, Yuksel MK, Ozcan M, Hacioglu SK, Barista I, Demirkaya M, Saydam G, Toprak SK, Yilmaz M, Demirkol O, Ferhanoglu B. Nivolumab for relapsed or refractory Hodgkin lymphoma: real- life experience. Ann Hematol. 2020 Jun 7. doi: 10.1007/s00277-020-04077-4. Epub ahead of print. PMID: 32507911.
        • Nagler A, Dholaria B, Labopin M, Savani BN, Angelucci E, Koc Y, Arat M, Pioltelli P, Sica S, Gülbas Z, Tischer J, Bernasconi P, Pavlu J, Socié G, Blaise D, Rigacci L, Martino M, Diez-Martin JL, Perić Z, Giebel S, Mohty M. Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemia. Leukemia. 2020 May 11. doi: 10.1038/s41375-020-0850-9. Epub ahead of print. PMID: 32393841.
        • Nagler A, Kanate AS, Labopin M, Ciceri F, Angelucci E, Koc Y, Gülbas Z, Arcese W, Tischer J, Pioltelli P, Ozdogu H, Afanasyev B, Wu D, Arat M, Peric Z, Giebel S, Savani B, Mohty M. Post-transplant cyclophosphamide versus anti- thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia. Haematologica. 2020 Apr 30:haematol.2020.247296. doi: 10.3324/haematol.2020.247296. Epub ahead of print. PMID: 32354866.
        • Penack O, Marchetti M, Ruutu T, Aljurf M, Bacigalupo A, Bonifazi F, Ciceri F, Cornelissen J, Malladi R, Duarte RF, Giebel S, Greinix H, Holler E, Lawitschka A, Mielke S, Mohty M, Arat M, Nagler A, Passweg J, Schoemans H, Socié G, Solano C, Vrhovac R, Zeiser R, Kröger N, Basak GW. Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation. Lancet Haematol. 2020 Feb;7(2):e157-e167. doi: 10.1016/S2352-3026(19)30256-X. PMID: 32004485.
        • Bazarbachi A, Labopin M, Angelucci E, Gülbas Z, Ozdogu H, Arat M, de Rosa L, Pastano R, Pioltelli P, Montserrat R, Martino M, Ciceri F, Koç Y, Socié G, Blaise D, Herrera C, Chalandon Y, Bernasconi P, Marotta G, Castagna L, McDonald A, Visani G, Carluccio P, Vitek A, Simand C, Afanasyev B, Rösler W, Diez-Martin JL, Nagler A, Brissot E, Giebel S, Mohty M. Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for T Cell Acute Lymphoblastic Leukemia: A Report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party. Biol Blood Marrow Transplant. 2020 May;26(5):936-942. doi: 10.1016/j.bbmt.2020.01.003. Epub 2020 Jan 9. PMID: 31926364.
        • Bazarbachi A, Boumendil A, Finel H, Castagna L, Dominietto A, Blaise D, Diez-Martin JL, Tischer J, Gülbas Z, Wallet HL, Corral LL, Mohty M, Koc Y, Yakoub-Agha I, Schmid C, El Cheikh J, Arat M, Forcade E, Dreger P, Rocha V, García GG, Chalandon Y, Ferra C, Orvain C, Robinson S, Montoto S, Sureda A. Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma - a LWP-EBMT study. Br J Haematol. 2020 Mar;188(5):745-756. doi: 10.1111/bjh.16182. Epub 2019 Sep 9. PMID: 31498883.
        • Domingo-Domènech E, Boumendil A, Climent F, Sengeloev H, Wahlin B, Wattad W, Arat M, Finel H, Schapp N, Ganser A, Yeshurun M, Pavone V, Snowden J, Finke J, Montoto S, Sureda A, Dreger P; Lymphoma Working Party of the European Society for Blood and Marrow Transplantation. Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT. Bone Marrow Transplant. 2020 Apr;55(4):796-803. doi: 10.1038/s41409-019-0734-7. Epub 2019 Nov 6. PMID: 31695174.
        • Attal M, Richardson PG, Rajkumar SV, San-Miguel J, Beksac M, Spicka I, Leleu X, Schjesvold F, Moreau P, Dimopoulos MA, Huang JS, Minarik J, Cavo M, Prince HM, Macé S, Corzo KP, Campana F, Le-Guennec S, Dubin F, Anderson KC; ICARIA-MM study group. Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study. Lancet. 2019 Dec 7;394(10214):2096-2107. doi: 10.1016/S0140-6736(19)32556-5. Epub 2019 Nov 14. Erratum in: Lancet. 2019 Dec 7;394(10214):2072. PMID: 31735560.
        • Carré M, Porcher R, Finke J, Ehninger G, Koster L, Beelen D, Ganser A, Volin L, Lozano S, Friis L, Michallet M, Tischer J, Olavarria E, Cascon MJP, Iacobelli S, Koc Y, Jindra P, Arat M, de Witte T, Yakoub Agha I, Kröger N, Robin M. Role of Age and Hematopoietic Cell Transplantation-Specific Comorbidity Index in Myelodysplastic Patients Undergoing an Allotransplant: A Retrospective Study from the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2020 Mar;26(3):451-457. doi: 10.1016/j.bbmt.2019.10.015. Epub 2019 Oct 21. PMID: 31647984.
        • Mohty M, Malard F, Abecasis M, Aerts E, Alaskar AS, Aljurf M, Arat M, Bader P, Baron F, Basak G, Bazarbachi A, Blaise D, Ciceri F, Corbacioglu S, Dalle JH, Dignan F, Fukuda T, Huynh A, Kuball J, Lachance S, Lazarus H, Masszi T, Michallet M, Nagler A, NiChonghaile M, Okamoto S, Pagliuca A, Peters C, Petersen FB, Richardson PG, Ruutu T, Saber W, Savani BN, Soiffer R, Styczynski J, Wallhult E, Yakoub-Agha I, Duarte RF, Carreras E. Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert group. Bone Marrow Transplant. 2020 Mar;55(3):485-495. doi: 10.1038/s41409-019-0705-z. Epub 2019 Oct 1. PMID: 31576023; PMCID: PMC7051913.
        • Halkes C, de Wreede LC, Knol C, Simand C, Aljurf M, Tbakhi A, Vazquez L, Bloor A, Wagner-Drouet E, Vural F, Bodova I, Isaksson C, Diaz MÁ, Gruhn B, Snowden J, Arat M, Bazarbachi A, Spilleboudt C, Kulagin A, Marsh JC, Passweg J, Risitano AM, Peffault de Latour R, Dufour C; European Society for Blood and Marrow Transplantation Severe Aplastic Anemia Working Party. Allogeneic stem cell transplantation for acquired pure red cell aplasia. Am J Hematol. 2019 Nov;94(11):E294-E296. doi: 10.1002/ajh.25609. Epub 2019 Sep 9. PMID: 31396977
        • Radujkovic A, Dietrich S, Blok HJ, Nagler A, Ayuk F, Finke J, Tischer J, Mayer J, Koc Y, Sorà F, Passweg J, Byrne JL, Jindra P, Veelken JH, Socié G, Maertens J, Schaap N, Stadler M, Itälä-Remes M, Tholouli E, Arat M, Rocha V, Ljungman P, Yakoub-Agha I, Kröger N, Chalandon Y. Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies Working Party. Biol Blood Marrow Transplant. 2019 Oct;25(10):2008-2016. doi: 10.1016/j.bbmt.2019.06.028. Epub 2019 Jul 1. PMID: 31271884.
        • Korkmaz S, Solmaz Medeni S, Demirkan F, Kalayoglu Besisik S, Altay Dadin S, Akgun Cagliyan G, Kabukcu Hacioglu S, Sari I, Goren Sahin D, Arat M, Dagdas S, Ozet G, Kutlu N, Karaagac Akyol T, Ozcebe OI, Uskudar Teke H, Kiper Unal D, Guner N, Tombak A, Celik H, Bay I, Kiki I, Ozgur G, Erkurt MA, Ozatli D, Meletli O, Demircioglu S, Demir C, Kurtoglu E, Vural F, Tobu M, Karakus A, Ayyildiz O, Dal MS, Afacan Ozturk B, Albayrak M, Ocakci S, Bolaman Z, Sonmez M, Karakus V, Gokmen Sevindik O, Berber I, Dogu MH, Gulturk E, Ulas T, Payzin B, Kuku I, Cagirgan S, Altuntas F. The Turkish experience with therapeutic plasma exchange: A national survey. Transfus Apher Sci. 2019 Jun;58(3):287-292. doi: 10.1016/j.transci.2019.04.015. Epub 2019 Apr 23. PMID: 31036516.
        • Passweg JR, Baldomero H, Basak GW, Chabannon C, Corbacioglu S, Duarte R, Kuball J, Lankester A, Montoto S, de Latour RP, Snowden JA, Styczynski J, Yakoub-Agha I, Arat M, Mohty M, Kröger N; European Society for Blood and Marrow Transplantation (EBMT). The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies. Bone Marrow Transplant. 2019 Oct;54(10):1575-1585. doi: 10.1038/s41409-019-0465-9. Epub 2019 Feb 6. PMID: 30728439; PMCID: PMC6957459. 
        • Cesaro S, Crocchiolo R, Tridello G, Knelange N, Van Lint MT, Koc Y, Ciceri F, Gülbas Z, Tischer J, Afanasyev B, Bruno B, Castagna L, Blaise D, Mohty M, Irrera G, Diez-Martin JL, Pierelli L, Pioltelli P, Arat M, Delia M, Fagioli F, Ehninger G, Aljurf M, Carella AM, Ozdogu H, Mikulska M, Ljungman P, Nagler A, Styczynski J. Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT. Bone Marrow Transplant. 2018 Apr;53(4):422-430. doi: 10.1038/s41409-017-0016-1. Epub 2018 Jan 12. PMID: 29330396. 
        • Goren Sahin D, Arat M. Peripheral blood stem cell collection for allogeneic hematopoietic stem cell transplantation: Practical implications after 200 consequent transplants. Transfus Apher Sci. 2017 Dec;56(6):800-803. doi: 10.1016/j.transci.2017.11.009. Epub 2017 Nov 8. PMID: 29162402.
        • Tekgündüz E, Arat M, Göker H, Özdoğu H, Kaynar L, Çağırgan S, Erkurt MA, Vural F, Kiki İ, Altuntaş F, Demirkan F; Turkish Society of Apheresis (TSA). Autologous hematopoietic progenitor cell mobilization and collection in adult patients presenting with multiple myeloma and lymphoma: A position-statement from the Turkish Society of Apheresis (TSA). Transfus Apher Sci. 2017 Dec;56(6):845-849. doi: 10.1016/j.transci.2017.11.025. Epub 2017 Nov 10. PMID: 29153306. 
        • Tekgündüz E, Demirkan F, Vural F, Göker H, Özdoğu H, Kiki İ, Aydoğdu İ, Kaynar L, Erkurt MA, Çağırgan S, Beşışık S, Dağdaş S, Koca E, Kadıköylü G, Gündüz E, Yılmaz M, Beköz H, Ural AU, Baştürk A, Arat M, Albayrak M, Öztürk E, Akyol A, Bolaman AZ, Nevruz O, Özkan HA, Özgür G, Altuntaş F. Current practice of autologous hematopoietic progenitor cell mobilization in adult patients with multiple myeloma and lymphoma: The results of a survey from Turkish hematology research and education group (ThREG). Transfus Apher Sci. 2017 Dec;56(6):804-808. doi: 10.1016/j.transci.2017.11.010. Epub 2017 Nov 9. PMID: 29153305. 
        • Beköz H, Karadurmuş N, Paydaş S, Türker A, Toptaş T, Fıratlı Tuğlular T, Sönmez M, Gülbaş Z, Tekgündüz E, Kaya AH, Özbalak M, Taştemir N, Kaynar L, Yıldırım R, Karadoğan I, Arat M, Pepedil Tanrıkulu F, Özkocaman V, Abalı H, Turgut M, Kurt Yüksel M, Özcan M, Doğu MH, Kabukçu Hacıoğlu S, Barışta I, Demirkaya M, Köseoğlu FD, Toprak SK, Yılmaz M, Demirkürek HC, Demirkol O, Ferhanoğlu B. Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience. Ann Oncol. 2017 Oct 1;28(10):2496-2502. doi: 10.1093/annonc/mdx341. PMID: 28961828.
        • DeFilipp Z, Duarte RF, Snowden JA, Majhail NS, Greenfield DM, Miranda JL, Arat M, Baker KS, Burns LJ, Duncan CN, Gilleece M, Hale GA, Hamadani M, Hamilton BK, Hogan WJ, Hsu JW, Inamoto Y, Kamble RT, Lupo-Stanghellini MT, Malone AK, McCarthy P, Mohty M, Norkin M, Paplham P, Ramanathan M, Richart JM, Salooja N, Schouten HC, Schoemans H, Seber A, Steinberg A, Wirk BM, Wood WA, Battiwalla M, Flowers ME, Savani BN, Shaw BE. Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT. Bone Marrow Transplant. 2017 Feb;52(2):173-182. doi: 10.1038/bmt.2016.203. Epub 2016 Aug 22. PMID: 27548466; PMCID: PMC5288134.
        • Efe İris N, Diz-Küçükkaya R, Arat M, Eriş Z. Bullous Pyoderma Gangrenosum in a Patient with Acute Myelogenous Leukemia as a Pathergic Reaction after Bone Marrow Biopsy. Turk J Haematol. 2017 Dec 1;34(4):350-351. doi: 10.4274/tjh.2016.0096. Epub 2016 Jun 17. PMID: 27313098; PMCID: PMC5774376
        • Efe İris N, Güvenç S, Özçelik T, Demirel A, Koçulu S, Çevik E, Arat M. Successful Treatment of Disseminated Fusariosis with the Combination of Voriconazole and Liposomal Amphotericin B. Turk J Haematol. 2016 Dec 1;33(4):363-364. doi: 10.4274/tjh.2016.0128. Epub 2016 Jun 17. PMID: 27311328; PMCID: PMC5204201.
        • DeFilipp Z, Duarte RF, Snowden JA, Majhail NS, Greenfield DM, Miranda JL, Arat M, Baker KS, Burns LJ, Duncan CN, Gilleece M, Hale GA, Hamadani M, Hamilton BK, Hogan WJ, Hsu JW, Inamoto Y, Kamble RT, Lupo-Stanghellini MT, Malone AK, McCarthy P, Mohty M, Norkin M, Paplham P, Ramanathan M, Richart JM, Salooja N, Schouten HC, Schoemans H, Seber A, Steinberg A, Wirk BM, Wood WA, Battiwalla M, Flowers MED, Savani BN, Shaw BE; CIBMTR Late Effects and Quality of Life Working Committee; EBMT Complications and Quality of Life Working Party. Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT. Biol Blood Marrow Transplant. 2016 Aug;22(8):1493-1503. doi: 10.1016/j.bbmt.2016.05.007. Epub 2016 May 14. PMID: 27184625; PMCID: PMC4949101.
        • Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, Arat M, Bader P, Baron F, Bazarbachi A, Blaise D, Ciceri F, Corbacioglu S, Dalle JH, Dignan F, Fukuda T, Huynh A, Masszi T, Michallet M, Nagler A, NiChonghaile M, Okamoto S, Pagliuca A, Peters C, Petersen FB, Richardson PG, Ruutu T, Savani BN, Wallhult E, Yakoub-Agha I, Duarte RF, Carreras E. Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant. 2016 Jul;51(7):906-12. doi: 10.1038/bmt.2016.130. Epub 2016 May 16. PMID: 27183098; PMCID: PMC4935979.
        • Özen M, Üstün C, Öztürk B, Topçuoğlu P, Arat M, Gündüz M, Atilla E, Bolat G, Arslan Ö, Demirer T, Akan H, İlhan O, Beksaç M, Gürman G, Özcan M. Allogeneic Transplantation in Chronic Myeloid Leukemia and the Effect of Tyrosine Kinase Inhibitors on Survival: A Quasi-Experimental Study. Turk J Haematol. 2017 Mar 1;34(1):16-26. doi: 10.4274/tjh.2015.0346. Epub 2016 Apr 18. PMID: 27094579; PMCID: PMC5451684.
        • Göksoy HS, Arat M. The use of second allogeneic hematopoietic stem cell transplantation for hematologic malignancies relapsed after the first: Does it worth to do? Transfus Apher Sci. 2016 Feb;54(1):91-8. doi: 10.1016/j.transci.2016.01.020. Epub 2016 Feb 26. PMID: 26976480.
        • Tekgündüz E, Şencan İ, Kapuağası A, Ünal D, Öztürk M, Gümüş E, Göker H, Tavil EB, Ertem M, Çetin M, Arat M, Soysal T, Karakaşlı O, Sur HY, Yeşilipek A, Ferhanoğlu B, Uçkan D, İlhan O, Altuntaş F. Hematopoietic cell transplantation activity of Turkey in 2014: Ongoing increase in HCT rates. Transfus Apher Sci. 2016 Feb;54(1):53-9. doi: 10.1016/j.transci.2016.01.013. Epub 2016 Jan 11. PMID: 26899916.
        • Fioredda F, Iacobelli S, van Biezen A, Gaspar B, Ancliff P, Donadieu J, Aljurf M, Peters C, Calvillo M, Matthes-Martin S, Morreale G, van 't Veer- Tazelaar N, de Wreede L, Al Seraihy A, Yesilipek A, Fischer A, Bierings M, Ozturk G, Smith O, Veys P, Ljungman P, Peffault de Latour R, Sánchez de Toledo Codina J, Or R, Ganser A, Afanasyev B, Wynn R, Kalwak K, Marsh J, Dufour C; Severe Aplastic Anemia the Inborn Error, and the Pediatric Disease Working Parties of the European Society for Blood and Bone Marrow Transplantation (EBMT) and Stem Cell Transplant for Immunodeficiencies in Europe (SCETIDE). Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation. Blood. 2015 Oct 15;126(16):1885-92; quiz 1970. doi: 10.1182/blood-2015-02-628859. Epub 2015 Jul 16. PMID: 26185129.
        • Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, Arat M, Bader P, Baron F, Bazarbachi A, Blaise D, Ciceri F, Corbacioglu S, Dalle JH, Duarte RF, Fukuda T, Huynh A, Masszi T, Michallet M, Nagler A, NiChonghaile M, Pagluica T, Peters C, Petersen FB, Richardson PG, Ruutu T, Savani BN, Wallhult E, Yakoub- Agha I, Carreras E. Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 2015 Jun;50(6):781-9. doi: 10.1038/bmt.2015.52. Epub 2015 Mar 23. PMID: 25798682; PMCID: PMC4456788.
        • Lawitschka A, Faraci M, Yaniv I, Veys P, Bader P, Wachowiak J, Socie G, Aljurf MD, Arat M, Boelens JJ, Duarte R, Tichelli A, Peters C. Paediatric reduced intensity conditioning: analysis of centre strategies on regimens and definitions by the EBMT Paediatric Diseases and Complications and Quality of Life WP. Bone Marrow Transplant. 2015 Apr;50(4):592-7. doi: 10.1038/bmt.2014.306. Epub 2015 Jan 26. PMID: 25621804. 
        • Akan H, Ongören Aydın S, Saltoğlu N, Cağatay A, Akalın H, Arat M, Ali R, Kalayoğlu-Beşışık S, Demir AM. Recommendations for the Treatment of Invasive Fungal Infections in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-1). Turk J Haematol. 2014 Jun;31(2):111-20. doi: 10.4274/tjh.2014.0103. Epub 2014 Jun 10. PMID: 25035667; PMCID: PMC4102037.
        • Bakanay SM, Kaygusuz G, Topçuoğlu P, Sengül S, Tunçalı T, Keven K, Kuzu I, Uysal A, Arat M. Epstein-barr virus-negative post-transplant lymphoproliferative diseases: three distinct cases from a single center. Turk J Haematol. 2014 Mar;31(1):79-83. doi: 10.4274/Tjh.2012.0010. Epub 2014 Mar 5. PMID: 24764734; PMCID: PMC3996636.
        • Passweg JR, Baldomero H, Peters C, Gaspar HB, Cesaro S, Dreger P, Duarte RF, Falkenburg JH, Farge-Bancel D, Gennery A, Halter J, Kröger N, Lanza F, Marsh J, Mohty M, Sureda A, Velardi A, Madrigal A; European Society for Blood and Marrow Transplantation EBMT. Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation. Bone Marrow Transplant. 2014 Jun;49(6):744-50. doi: 10.1038/bmt.2014.55. Epub 2014 Mar 17. PMID: 24637898; PMCID: PMC4051369.
        • Bilgin AU, Topcuoğlu P, Sancak T, Konuk N, Arat M. Intramesenteric steroid treatment for steroid- refractory gastrointestinal graft versus host disease. Turk J Haematol. 2012 Dec;29(4):409-12. doi: 10.5505/tjh.2012.57855. Epub 2012 Dec 5. PMID: 24385731; PMCID: PMC3781620.
        • Bakanay ŞM, Bilgin AU, Bektaş M, Idilman R, Erden E, Arat M, Arslan Ö. Vanishing bile duct syndrome after allogeneic bone marrow transplantation: is it the end of the road? Turk J Gastroenterol. 2013;24(4):359-62. doi: 10.4318/tjg.2013.0604. PMID: 24254270. 
        • Bozdag SC, Topcuoglu P, Kuzu I, Arat M. Acute lymphoblastic leukemia during enzyme replacement therapy in type 1 Gaucher's disease. Clin Adv Hematol Oncol. 2013 Apr;11(4):251-2. PMID: 23604243.
        • Tichelli A, Labopin M, Rovó A, Badoglio M, Arat M, van Lint MT, Lawitschka A, Schwarze CP, Passweg J, Socié G. Increase of suicide and accidental death after hematopoietic stem cell transplantation: a cohort study on behalf of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Cancer. 2013 Jun 1;119(11):2012-21. doi: 10.1002/cncr.27987. Epub 2013 Mar 19. PMID: 23512286; PMCID: PMC3698695.
        • Rovó A, Aljurf M, Chiodi S, Spinelli S, Salooja N, Sucak G, Hunter A, Kim TS, Socié G, van Lint MT, Passweg JR, Arat M, Badoglio M, Tichelli A. Paternity wishes in long-term survivors after allogeneic hematopoietic SCT. A study of the late effects working party of the EBMT. Bone Marrow Transplant. 2013 Jun;48(6):878-9. doi: 10.1038/bmt.2012.255. Epub 2013 Jan 7. PMID: 23292242.
        • Efe Iris N, Sayıner H, Yildirmak T, Simsek F, Arat ME. Vancomycin-resistant Enterococcus carrier status in the reanimation units and related risk factors. Am J Infect Control. 2013 Mar;41(3):261-2. doi: 10.1016/j.ajic.2012.04.331. Epub 2012 Oct 13. PMID: 23069738.
        • Rovó A, Aljurf M, Chiodi S, Spinelli S, Salooja N, Sucak G, Hunter A, Kim TS, Socié G, van Lint MT, Passweg JR, Arat M, Badoglio M, Tichelli A; Late Effects Working Party of the EBMT. Ongoing graft-versus-host disease is a risk factor for azoospermia after allogeneic hematopoietic stem cell transplantation: a survey of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica. 2013 Mar;98(3):339-45. doi: 10.3324/haematol.2012.071944. Epub 2012 Aug 28. PMID: 22929982; PMCID: PMC3659920.
        • Gürgan CA, Özcan M, Karakuş Ö, Zincircioğlu G, Arat M, Soydan E, Topcuoglu P, Gürman G, Bostancı HS. Periodontal status and post-transplantation complications following intensive periodontal treatment in patients underwent allogenic hematopoietic stem cell transplantation conditioned with myeloablative regimen. Int J Dent Hyg. 2013 May;11(2):84-90. doi: 10.1111/j.1601-5037.2012.00550.x. Epub 2012 Apr 9. PMID: 22487659.
        • Yegin ZA, Arat M. A survey of hematologists on compulsory health service in Turkey. Turk J Haematol. 2011 Dec 5;28(4):335-6. English. doi: 10.5152/tjh.2011.91. PMID: 27264593.
        • Topcuoglu P, Arat M, Ozcan M, Arslan O, Ilhan O, Beksac M, Gurman G. Case- matched comparison with standard versus reduced intensity conditioning regimen in chronic myeloid leukemia patients. Ann Hematol. 2012 Apr;91(4):577-86. doi: 10.1007/s00277-011-1349-2. Epub 2011 Oct 5. PMID: 21971669.
        • Idilman R, Arat M. Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation. Expert Rev Anti Infect Ther. 2011 Aug;9(8):641-52. doi: 10.1586/eri.11.79. PMID: 21819330.
        • Gunay-Aygun M, Falik-Zaccai TC, Vilboux T, Zivony-Elboum Y, Gumruk F, Cetin M, Khayat M, Boerkoel CF, Kfir N, Huang Y, Maynard D, Dorward H, Berger K, Kleta R, Anikster Y, Arat M, Freiberg AS, Kehrel BE, Jurk K, Cruz P, Mullikin JC, White JG, Huizing M, Gahl WA. NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granules. Nat Genet. 2011 Jul 17;43(8):732-4. doi: 10.1038/ng.883. PMID: 21765412; PMCID: PMC3154019.
        • Idilman R, Bozkus Y, Seval G, Mizrak D, Cinar K, Ustun Y, Bektas M, Arat M, Akbulut H, Doganay B, Ozden A. Lymphoproliferative disorders in individuals with chronic hepatitis B and C in the Turkish population. J Med Virol. 2011 Jun;83(6):974-80. doi: 10.1002/jmv.21747. PMID: 21503909.
        • Solh M, Arat M, Cao Q, Majhail NS, Weisdorf D. Late-onset noninfectious pulmonary complications in adult allogeneic hematopoietic cell transplant recipients. Transplantation. 2011 Apr 15;91(7):798-803. doi: 10.1097/TP.0b013e31820c85fa. PMID: 21403586.
        • Tichelli A, Rovó A, Passweg J, Schwarze CP, Van Lint MT, Arat M, Socié G; Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Late complications after hematopoietic stem cell transplantation. Expert Rev Hematol. 2009 Oct;2(5):583-601. doi: 10.1586/ehm.09.48. PMID: 21083023.
        • Arat M, Ozsan GH, Yenerel MN, Cetin M, Ozcan M. 2nd International Congress on Leukemia, Lymphoma and Myeloma. Expert Rev Hematol. 2009 Oct;2(5):509-12. doi: 10.1586/ehm.09.50. PMID: 21083016.
        • Kabaçam G, Kabaçam G, Topçuoğlu P, Kuzu I, Arat M. Enzyme replacement therapy in type 1 Gaucher disease and a review of the literature. Turk J Haematol. 2010 Sep 5;27(3):190-5. English. doi: 10.5152/tjh.2010.27. PMID: 27263604.
        • Gunay-Aygun M, Zivony-Elboum Y, Gumruk F, Geiger D, Cetin M, Khayat M, Kleta R, Kfir N, Anikster Y, Chezar J, Arcos-Burgos M, Shalata A, Stanescu H, Manaster J, Arat M, Edwards H, Freiberg AS, Hart PS, Riney LC, Patzel K, Tanpaiboon P, Markello T, Huizing M, Maric I, Horne M, Kehrel BE, Jurk K, Hansen NF, Cherukuri PF, Jones M, Cruz P, Mullikin JC, Nurden A, White JG, Gahl WA, Falik-Zaccai T. Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p. Blood. 2010 Dec 2;116(23):4990-5001. doi: 10.1182/blood-2010-05-286534. Epub 2010 Aug 13. PMID: 20709904; PMCID: PMC3012593.
        • Şanlı H, Akay BN, Soydan E, Koçyiğit P, Arat M, İlhan O. Clinical Aspects Of Sclerodermatous Type Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation. Turk J Haematol. 2010 Jun 5;27(2):91-8. English. doi: 10.5152/tjh.2010.06. PMID: 27263450.
        • Akay BN, Sanli H, Topcuoglu P, Arat M, Akyol A. Nailfold capillary abnormalities are prevalent in sclerodermoid graft-versus-host disease and readily detected with dermatoscopy. Br J Dermatol. 2010 May;162(5):1076-82. doi: 10.1111/j.1365-2133.2010.09667.x. Epub 2010 Mar 5. PMID: 20222922.
        • Kurt RA, Yalçindag N, Atilla H, Arat M. Topical cyclosporine-A in dry eye associated with chronic graft versus host disease. Ann Ophthalmol (Skokie). 2009 Fall-Winter;41(3-4):166-9. PMID: 20214049. 
        • Gratwohl A, Stern M, Brand R, Apperley J, Baldomero H, de Witte T, Dini G, Rocha V, Passweg J, Sureda A, Tichelli A, Niederwieser D; European Group for Blood and Marrow Transplantation and the European Leukemia Net. Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. Cancer. 2009 Oct 15;115(20):4715-26. doi: 10.1002/cncr.24531. PMID: 19642176. 
        • Ozcelik T, Topcuoglu P, Beksac M, Ozcan M, Arat M, Biyikli Z, Bakanay SM, Ilhan O, Gurman G, Arslan O, Demirer T. Mobilization of PBSCs with chemotherapy and recombinant human G-CSF: a randomized evaluation of early vs late administration of recombinant human G-CSF. Bone Marrow Transplant. 2009 Dec;44(12):779-83. doi: 10.1038/bmt.2009.161. Epub 2009 Jul 13. PMID: 19597420. 
        • Akar AR, Durdu S, Arat M, Kilickap M, Kucuk NO, Arslan O, Kuzu I, Ozyurda U. Five-year follow-up after transepicardial implantation of autologous bone marrow mononuclear cells to ungraftable coronary territories for patients with ischaemic cardiomyopathy. Eur J Cardiothorac Surg. 2009 Oct;36(4):633-43. doi: 10.1016/j.ejcts.2009.04.045. Epub 2009 Jun 12. PMID: 19524451. 
        • Daikeler T, Hügle T, Farge D, Andolina M, Gualandi F, Baldomero H, Bocelli- Tyndall C, Brune M, Dalle JH, Urban C, Ehninger G, Gibson B, Linder B, Lioure B, Marmont A, Matthes-Martin S, Nachbaur D, Schuetz P, Tyndall A, van Laar JM, Veys P, Saccardi R, Gratwohl A; Working Party Autoimmune Diseases of the EBMT. Allogeneic hematopoietic SCT for patients with autoimmune diseases. Bone Marrow Transplant. 2009 Jul;44(1):27-33. doi: 10.1038/bmt.2008.424. Epub 2009 Jan 12. Erratum in: Bone Marrow Transplant. 2009 Jul;44(1):67. Urban, C [added]. PMID: 19139739. 
        • Ozden A, Süleyman Z, Seven G, Arat M, Akin A, Sener O, Kuzu I, Keven K, Ensari A, Erden A, Tan E. POEMS syndrome: a case report. Turk J Gastroenterol. 2008 Dec;19(4):276-80. PMID: 19119489.
        • Gratwohl A, Baldomero H, Frauendorfer K, Niederwieser D; Joint Accreditation Committee of the International Society for Cellular Therapy ISCT; European Group for Blood and Marrow Transplantation EMBT (JACIE). Why are there regional differences in stem cell transplantation activity? An EBMT analysis. Bone Marrow Transplant. 2008 Aug;42 Suppl 1:S7-S10. doi: 10.1038/bmt.2008.104. PMID: 18724308.